Header Logo

A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer.

A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Semin Oncol. 2003 Oct; 30(5 Suppl 16):117-24.

View in: PubMed